Table 1.
Single-locus targeting (pRPa) and other complementary constructs.
Constructs | Namea | Selectable Markerb |
Expression Cassette |
Tet- regulated |
Linearise with |
---|---|---|---|---|---|
pRPa | pRPaiSL | HYG | Stem-loop RNAic | Yes | AscI |
pRPaiGx | HYG | GFPx | Yes | AscI | |
pRPaixG | HYG | xGFP | Yes | AscI | |
pRPaiMx | HYG | Mycx | Yes | AscI | |
pRPaix6Mx | HYG | x6Mycx | Yes | AscI | |
| |||||
pRP d | pRPiMx | BSD | Mycx | Yes | NotI |
pRPix6Mx | BSD | x6Mycx | Yes | NotI | |
| |||||
pNATe | pNATxG | BSD | xGFP | No | f |
pNATx12M | BSD | x12Myc | No | f | |
pNATGx | BSD | GFPx | No | f | |
pNAT6Mx | BSD | 6Mycx | No | f |
RP, RRNA promoter controls the expression cassette; NAT, native locus controls expression; a, denotes AscI sites; i, inducible; SL, stem-loop; x, selected ORF; G, eGFP; M, cMyc epitope.
HYG, hygromycin-B phosphotransferase; BSD, blasticidin-S deaminase.
Different multiple cloning sites available: MCS1/2, MCS3/4 (see Fig. 1).
pRP constructs can integrate at any RRNA spacer locus and yield variable levels of expression upon induction in different clones.
The restriction enzyme used depends upon the specific ORF targeted.